Jack O'Brien
- Indexed articles, last 90 days
- 10
- Latest publication
- Sep 18, 2026
- Outlet visibility, for MM+M - Medical Marketing and Media
- Top 5M sites
- Earliest in this view
- Jul 27, 2026
Latest articles
Following MLB partnership, AbbVie tees off as PGA Tourâs official pharma sponsor (opens the original)
Read excerpt
Though the golf season is coming to a close, the pharma giant is doubling down on its sports partnerships by signing on as the official pharmaceutical sponsor of the PGA Tour and the 2026 Presidents Cup. With this golf-focused initiative, AbbVie is raising awareness of disease states and conditions impacting brain health, including migraine, behavioral issues and Parkinson’s disease. AbbVie noted that one-third of people around the world are impacted by neurological conditions, which increases t
Assembled Intelligence taps former PHM leader Andrea Palmer as CEO (opens the original)
Read excerpt
Andrea Palmer has jumped from her role as CEO of one MM+M Agency 100 honoree to soon serve as CEO of another. Assembled Intelligence unveiled Palmer as its new CEO Thursday morning. Palmer will succeed Mark Lydiatt, who has led Assembled Intelligence since its formation in 2024 and will continue to support the business as a member of the company’s board of directors. Palmer is a longtime veteran of Publicis who most recently served as CEO of PHM. Palmer spent nearly 20 years rising through the r
Why Allison launched Allison Worldwide Health Group (opens the original)
Read excerpt
Allison Worldwide unveiled Allison Worldwide Health Group on Wednesday afternoon, a sign that the Stagwell subsidiary is formalizing its presence in the medical marketing space. Allison Worldwide Health Group will operate as an integrated health communications offering designed to prioritize patient needs and break down longstanding silos between agency partners and their pharma and biotech clients. The group’s initial focus is on a number of key therapeutic areas, namely rare disease, women’s h
AI may be the future, but CMI emphasizes human-centricity at Agility (opens the original)
Read excerpt
The future of medical marketing will be shaped by the continued evolution and advancements in AI, but CMI also wants to keep the focus on the humans in the mix. Those two topics served as the leading — at times dueling — thematic elements of the 2026 MM+M Agency 100 honoree’s fourth annual Agility conference in Philadelphia on Monday. Following opening remarks from CMI CEO Susan Dorfman and Compas CEO Jim Woodland, the programming mapped out how one of the preeminent medical marketing agencies i
âA great year for the pharma in the NFLâ: EDO delivers 2025â26 season insights (opens the original)
Read excerpt
The NFL season kicks off in one week, and pharma brands are all too eager to get back on the gridiron. Pharma brands were among the top advertisers during the 2025-26 NFL regular season, according to the fourth annual NFL TV Outcomes Report released by EDO on Wednesday morning. The TV outcomes company found that three of the top five regular-season advertisers — including the top two — were pharma brands. Standout performers included Galderma’s Nemluvio, Novartis’ Pluvicto, Eli Lilly’s Ebglyss,
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For MM+M - Medical Marketing and Media, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.